From Basic Science to Biomedical Applications—Second Edition

Nunzianna Doti,Menotti Ruvo

DOI: https://doi.org/10.3390/ijms25021083

IF: 5.6

2024-01-16

International Journal of Molecular Sciences

Abstract:Peptides are increasingly emerging as a drug class for a wide range of human diseases due to their intrinsic properties, such as excellent recognition abilities and biocompatibility [...]

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

Recent Applications of Retro-Inverso Peptides

Nunzianna Doti,Mario Mardirossian,Annamaria Sandomenico,Menotti Ruvo,Andrea Caporale

DOI: https://doi.org/10.3390/ijms22168677

IF: 5.6

2021-08-12

International Journal of Molecular Sciences

Abstract:Natural and de novo designed peptides are gaining an ever-growing interest as drugs against several diseases. Their use is however limited by the intrinsic low bioavailability and poor stability. To overcome these issues retro-inverso analogues have been investigated for decades as more stable surrogates of peptides composed of natural amino acids. Retro-inverso peptides possess reversed sequences and chirality compared to the parent molecules maintaining at the same time an identical array of side chains and in some cases similar structure. The inverted chirality renders them less prone to degradation by endogenous proteases conferring enhanced half-lives and an increased potential as new drugs. However, given their general incapability to adopt the 3D structure of the parent peptides their application should be careful evaluated and investigated case by case. Here, we review the application of retro-inverso peptides in anticancer therapies, in immunology, in neurodegenerative diseases, and as antimicrobials, analyzing pros and cons of this interesting subclass of molecules.

biochemistry & molecular biology,chemistry, multidisciplinary
From Natural Sources to Therapeutics

Kruttika Purohit,Narsimha Reddy,Anwar Sunna

DOI: https://doi.org/10.3390/ijms25031391

IF: 5.6

2024-01-24

International Journal of Molecular Sciences

Abstract:Bioactive peptides, specific protein fragments with positive health effects, are gaining traction in drug development for advantages like enhanced penetration, low toxicity, and rapid clearance. This comprehensive review navigates the intricate landscape of peptide science, covering discovery to functional characterization. Beginning with a peptidomic exploration of natural sources, the review emphasizes the search for novel peptides. Extraction approaches, including enzymatic hydrolysis, microbial fermentation, and specialized methods for disulfide-linked peptides, are extensively covered. Mass spectrometric analysis techniques for data acquisition and identification, such as liquid chromatography, capillary electrophoresis, untargeted peptide analysis, and bioinformatics, are thoroughly outlined. The exploration of peptide bioactivity incorporates various methodologies, from in vitro assays to in silico techniques, including advanced approaches like phage display and cell-based assays. The review also discusses the structure–activity relationship in the context of antimicrobial peptides (AMPs), ACE-inhibitory peptides (ACEs), and antioxidative peptides (AOPs). Concluding with key findings and future research directions, this interdisciplinary review serves as a comprehensive reference, offering a holistic understanding of peptides and their potential therapeutic applications.

biochemistry & molecular biology,chemistry, multidisciplinary
Peptide Drugs: Current Status and it's Applications in the Treatment of Various Diseases

Chandni Chandarana,Isha Juwarwala,Shravi Shetty,Anushree Bose

DOI: https://doi.org/10.2174/0125899775295960240406073630

Abstract:Peptides represent a class of natural molecules with diverse physiological functions, including hormone regulation, neurotransmission, and immune modulation. In recent years, peptide- based therapeutics have gained significant attention in pharmaceutical research and development due to their high specificity, efficacy, and relatively low toxicity. This review provides an overview of the current landscape of peptide drug development, highlighting the challenges faced in their formulation and delivery and the innovative strategies employed to overcome these hurdles. The review explores the wide range of applications of peptide drugs in treating various diseases, including HIV, multiple sclerosis, osteoporosis, chronic pain, diabetes, and cancer. Examples of FDA-approved peptide drugs and ongoing clinical trials are presented, showcasing the continuous advancements in peptide-based therapeutics across different therapeutic areas. This review underscores the promising potential of peptide drugs as targeted and effective treatments for a multitude of medical conditions, offering improved therapeutic outcomes and enhanced patient care.
The Search for Peptide-Based Therapeutics Using Computational Tools

Marian Vincenzi,Flavia Anna Mercurio,Marilisa Leone

DOI: https://doi.org/10.3390/ijms25031798

IF: 5.6

2024-02-02

International Journal of Molecular Sciences

Abstract:Over the last few decades, we have witnessed growing interest from both academic and industrial laboratories in peptides as possible therapeutics. Bioactive peptides have a high potential to treat various diseases with specificity and biological safety. Compared to small molecules, peptides represent better candidates as inhibitors (or general modulators) of key protein–protein interactions. In fact, undruggable proteins containing large and smooth surfaces can be more easily targeted with the conformational plasticity of peptides. The discovery of bioactive peptides, working against disease-relevant protein targets, generally requires the high-throughput screening of large libraries, and in silico approaches are highly exploited for their low-cost incidence and efficiency. The present review reports on the potential challenges linked to the employment of peptides as therapeutics and describes computational approaches, mainly structure-based virtual screening (SBVS), to support the identification of novel peptides for therapeutic implementations. Cutting-edge SBVS strategies are reviewed along with examples of applications focused on diverse classes of bioactive peptides (i.e., anticancer, antimicrobial/antiviral peptides, peptides blocking amyloid fiber formation).

biochemistry & molecular biology,chemistry, multidisciplinary
Peptides for therapeutic applications – challenges and chances

Chiara Ruggirello,Karin Mörl,Annette G. Beck-Sickinger

DOI: https://doi.org/10.1515/pac-2024-0104

2024-03-02

Pure and Applied Chemistry

Abstract:Peptides have beneficial properties for therapeutic applications due to their excellent target specificity, high affinity and activity, low toxicity and predictable metabolism. Thus, they became an important tool for research and medical purpose. However, peptides are fragile molecules, therefore, in order to be used as therapeutic agents they need to be stabilised by non-peptidic modifications. Required improvements of these peptide properties include longer half-life, higher bioavailability, increased potency and efficiency. Strategies to achieve these goals have been identified in the last years, with synthetic strategies to obtain sufficient amounts becoming increasingly important. In this review, peptides are discussed with respect to their therapeutic applications. Examples from glucagon-like peptide 1 receptor agonists are shown. Peptides are compared to small molecules and antibodies with respect to advantages and disadvantages in therapeutic applications.

chemistry, multidisciplinary
Peptides as drugs: from screening to application

Ursula Dietrich,Ralf Dürr,Joachim Koch

DOI: https://doi.org/10.2174/13892010113149990205

Abstract:Peptides are ideally suited to mimic natural ligands and thereby function in an antagonistic or agonistic way. Furthermore they are able to physiologically disrupt functional complexes due to their small size and specific binding properties. Proteins form homo- or heteromeric (macro)molecular complexes and intricate networks by interacting with small molecules, peptides, nucleic acids or other proteins. On average, five interaction partners have been estimated for any given cellular protein, illustrating the complexity of the formed 'interactomes' and the impact of their investigation. Many protein-protein interactions are mediated by hot-spots, which comprise only a small part of the large binding interface but account for 80% of the binding energy. Thus, these hot spots provide an 'Achilles heel' for pharmaceutical interventions aiming at the disruption of functional protein-protein complexes. Methods to select peptides for defined target structures include display technologies on phages, ribosomes or yeast, and the yeast-two-hybrid system. Once selected, these peptides can be optimized for their binding affinity using peptide arrays. Stabilization of biologically unstable peptides is achieved by the introduction of non-natural amino acids to form so-called peptidomimetics that are resistant to cellular proteases. Moreover, lipocalins and peptide aptamers represent scaffolded binding structures with unique binding characteristics and enhanced stability. In case of extracellular targets, like cell surface receptors or pathogens in patients` plasma, peptide inhibitors have direct access. Addressing intracellular targets with peptides is more difficult since short hydrophilic peptides generally do not cross plasma membranes on their own. However, intracellular uptake of peptides can be achieved by coupling to carrier systems like liposomes or nanoparticles or upon fusion to a protein transduction domain. Alternatively, peptides may be expressed within cells after transduction with viral vectors in a gene therapy setting. This review will summarize the broad potential of peptides as drugs, with special emphasis on peptides which inhibit protein-protein interactions.
Advancements in peptide-based therapeutics: Design, synthesis and clinical applications

Swamita Arora Mukul Singh,Saiphali, G. Dharmamoorthy Dharmendra Bhati,Tanya Gupta, Ankur Patel Abhishek Bhattacharjee,Pankaj Bhatt

DOI: https://doi.org/10.51470/bca.2023.23.s1.1415

2023-12-20

Abstract:Peptide-based therapeutics have emerged as a dynamic and versatile class of drugs with profound implications for modern medicine. This comprehensive review encompasses the key advancements in peptide design strategies, synthesis techniques, delivery systems, and clinical applications. Rational design approaches, including structure-activity relationship (SAR) studies and molecular modeling have revolutionized peptide design, enabling precise targeting and therapeutic optimization. Advances in peptide synthesis techniques, such as solid-phase peptide synthesis (SPPS) and native chemical ligation (NCL), have improved production efficiency and scalability. Peptide delivery systems, including nanoparticles, liposomes, polymers and cell-penetrating peptides (CPPs), offer enhanced bioavailability and targeted drug delivery. In clinical applications, peptide-based therapeutics span endocrine disorders, antimicrobial therapy, cancer treatment, immunomodulation, neurological disorders and cardiovascular diseases, demonstrating their wide-ranging impact on healthcare. Challenges in regulatory approval, immunogenicity, and toxicity are addressed, with an emphasis on personalized medicine and emerging modalities. Case studies highlight successful peptide-based drugs on the market, ongoing clinical trials, and real-world patient outcomes. In conclusion, this review underscores the potential of peptide-based therapeutics to revolutionize personalized and precision medicine, shaping the future of healthcare with tailored solutions to complex medical challenges.
Therapeutic Peptides and Proteins: Stabilization Challenges and Biomedical Applications by Means of Nanodelivery Systems

Elisa Berselli,Carlotta Coccolini,Giovanni Tosi,Evren H. Gökçe,M. Beatriz P. P. Oliveira,Faezeh Fathi,Karolline Krambeck,Eliana B. Souto,Krambeck, Karolline

DOI: https://doi.org/10.1007/s10989-024-10592-z

2024-02-29

International Journal of Peptide Research and Therapeutics

Abstract:The delivery of peptides and proteins usually faces formulation development challenges attributed to the difficulties encountered in their stabilization. Nanoparticles offer an alternative to improve the physicochemical stability of such biomacromolecules, while increasing their bioavailability by overcoming biological absorption barriers. With this review, we aim to discuss the stability problems of proteins and peptides that have driven the scientific community to find in nanotechnology a valid alternative for oral administration of biomolecules. In addition, we describe the most commonly used nanoparticles for this purpose (e.g., polymers such as polylactic acid, poly(lactic-co-glycolic acid), polycaprolactone, modified chitosan, and lipids such as oil-in-water nanoemulsions, self-emulsified drug delivery systems, solid lipid nanoparticles, nanostructured lipid carriers, liposomes, as well as hybrid systems like micelles), and we show some of the most important recent applications of these nanoparticles for the delivery of proteins and peptides, including for the treatment of diabetes, viruses (such as HIV), cancer, as well as in the development of vaccines.

biochemistry & molecular biology
The Medicinal Chemistry of Therapeutic Peptides: Recent Developments in Synthesis and Design Optimizations

Anutthaman Parthasarathy,Sasikala K Anandamma,Karunakaran A Kalesh,Sasikala K. Anandamma,Karunakaran A. Kalesh

DOI: https://doi.org/10.2174/0929867324666171012103559

IF: 4.74

2019-07-08

Current Medicinal Chemistry

Abstract:Peptide therapeutics has made tremendous progress in the past decade. Many of the inherent weaknesses of peptides which hampered their development as therapeutics are now more or less effectively tackled with recent scientific and technological advancements in integrated drug discovery settings. These include recent developments in synthetic organic chemistry, high-throughput recombinant production strategies, highresolution analytical methods, high-throughput screening options, ingenious drug delivery strategies and novel formulation preparations. Here, we will briefly describe the key methodologies and strategies used in the therapeutic peptide development processes with selected examples of the most recent developments in the field. The aim of this review is to highlight the viable options a medicinal chemist may consider in order to improve a specific pharmacological property of interest in a peptide lead entity and thereby rationally assess the therapeutic potential this class of molecules possesses while they are traditionally (and incorrectly) considered ‘undruggable’.

pharmacology & pharmacy,biochemistry & molecular biology,chemistry, medicinal
The Century-Long Journey of Peptide-Based Drugs

José R. Almeida

DOI: https://doi.org/10.3390/antibiotics13030196

2024-02-20

Antibiotics

Abstract:The pioneering medical application of peptides as therapeutics began approximately a century ago; however, they remain clinically relevant candidates garnering more attention on the drug development agenda [...]

pharmacology & pharmacy,infectious diseases
Overcoming the shortcomings of peptide-based therapeutics

Christina Lamers

DOI: https://doi.org/10.4155/fdd-2022-0005

2022-07-12

Future Drug Discovery

Abstract:Peptides have traditionally been perceived as poor drug candidates due to unfavorable characteristics mainly regarding their pharmacokinetic behavior, including plasma stability, membrane permeability and circulation half-life. Nonetheless, in recent years, general strategies to tackle those shortcomings have been established, and peptides are subsequently gaining increasing interest as drugs due to their unique ability to combine the advantages of antibodies and small molecules. Macrocyclic peptides are a special focus of drug development efforts due to their ability to address so called 'undruggable' targets characterized by large and flat protein surfaces lacking binding pockets. Here, the main strategies developed to date for adapting peptides for clinical use are summarized, which may soon help usher in an age highly shaped by peptide-based therapeutics. Nonetheless, limited membrane permeability is still to overcome before peptide therapeutics will be broadly accepted.
Peptide-Based Biomaterials for Combatting Infections and Improving Drug Delivery

Lucia Lombardi,Jiaxu Li,Daryl R. Williams

DOI: https://doi.org/10.3390/pharmaceutics16111468

IF: 6.525

2024-11-27

Pharmaceutics

Abstract:This review explores the potential of peptide-based biomaterials to enhance biomedical applications through self-assembly, biological responsiveness, and selective targeting. Peptides are presented as versatile agents for antimicrobial activity and drug delivery, with recent approaches incorporating antimicrobial peptides into self-assembling systems to improve effectiveness and reduce resistance. The review also covers peptide-based nanocarriers for cancer drug delivery, highlighting their improved stability, targeted delivery, and reduced side effects. The focus of this work is on the bioactive properties of peptides, particularly in infection control and drug delivery, rather than on their structural design or material characteristics. Additionally, it examines the role of peptidomimetics in broadening biomaterial applications and enhancing resistance to enzymatic degradation. Finally, the review discusses the commercial prospects and challenges of translating peptide biomaterials into clinical applications.

pharmacology & pharmacy
Recent CPP-based applications in medicine

Kaido Kurrikoff,Ülo Langel

DOI: https://doi.org/10.1080/17425247.2019.1665021

2019-09-17

Expert Opinion on Drug Delivery

Abstract:Introduction: Cell-penetrating peptides (CPP) offer versatile tools for the field of drug delivery and development of macromolecular therapeutics. These tools have matured into applications that allow the use of proteins, nucleic acid, peptides, imaging agents, and low molecular weight drugs as therapeutic entities.Areas covered: The progress of the field is discussed in the current review, with the examples from a recent couple of years, in the utilization of CPPs in medicine. Specific focus is on the research articles that include applications that have direct translational value. Progress with protein mimicry and its recent leap in medicine is discussed with special attention, but also achievements with nanoformulation and drug targeting is presented.Expert opinion: The opinion section discusses some of the limitations and shortcomings, proposing the areas where more effort should be invested in order to increase the translational value of the current preclinical research.

pharmacology & pharmacy
Recent Advances and Computational Approaches in Peptide Drug Discovery

Neha S Maurya,Sandeep Kushwaha,Ashutosh Mani,Neha S. Maurya

DOI: https://doi.org/10.2174/1381612825666190911161106

IF: 3.31

2019-11-14

Current Pharmaceutical Design

Abstract:Background: Drug design and development is a vast field that requires huge investment along with a long duration for providing approval to suitable drug candidates. With the advancement in the field of genomics, the information about druggable targets is being updated at a fast rate which is helpful in finding a cure for various diseases. Methods: There are certain biochemicals as well as physiological advantages of using peptide-based therapeutics. Additionally, the limitations of peptide-based drugs can be overcome by modulating the properties of peptide molecules through various biomolecular engineering techniques. Recent advances in computational approaches have been helpful in studying the effect of peptide drugs on the biomolecular targets. Receptor – ligand-based molecular docking studies have made it easy to screen compatible inhibitors against a target.Furthermore, there are simulation tools available to evaluate stability of complexes at the molecular level. Machine learning methods have added a new edge by enabling accurate prediction of therapeutic peptides. Results: Peptide-based drugs are expected to take over many popular drugs in the near future due to their biosafety, lower off-target binding chances and multifunctional properties. Conclusion: This article summarises the latest developments in the field of peptide-based therapeutics related to their usage, tools, and databases.

pharmacology & pharmacy
Peptides as Targeting Agents and Therapeutics: A Brief Overview

Jalissa L Warthen,Michael J Lueckheide

DOI: https://doi.org/10.1021/acs.biomac.4c00518

2024-11-11

Biomacromolecules

Abstract:The controllability and specificity of peptides make them ideal for targeting therapeutic delivery systems and as therapeutic agents that interfere with the essential functions of pathogens and tumors. Peptides can also mimic natural protein structures or parts thereof, agonize receptors, and be conjugated to other molecules that will self-assemble. In this short Review, we discuss research from the last ten years into peptide use in three arenas: the treatment of cancer, the treatment of pathogens, and the targeting of specific organs and organelles. These studies demonstrate the successful application of targeting and therapeutic peptides in vitro and in vivo and show the promising range of applications peptides can have going forward.
Therapeutic peptides: current applications and future directions

Lei Wang,Nanxi Wang,Wenping Zhang,Xurui Cheng,Zhibin Yan,Gang Shao,Xi Wang,Rui Wang,Caiyun Fu

DOI: https://doi.org/10.1038/s41392-022-00904-4

IF: 39.3

2022-02-14

Signal Transduction and Targeted Therapy

Abstract:Abstract Peptide drug development has made great progress in the last decade thanks to new production, modification, and analytic technologies. Peptides have been produced and modified using both chemical and biological methods, together with novel design and delivery strategies, which have helped to overcome the inherent drawbacks of peptides and have allowed the continued advancement of this field. A wide variety of natural and modified peptides have been obtained and studied, covering multiple therapeutic areas. This review summarizes the efforts and achievements in peptide drug discovery, production, and modification, and their current applications. We also discuss the value and challenges associated with future developments in therapeutic peptides.

biochemistry & molecular biology,cell biology
Structural information in therapeutic peptides: Emerging applications in biomedicine

Valentín Iglesias,Oriol Bárcenas,Carlos Pintado‐Grima,Michał Burdukiewicz,Salvador Ventura

DOI: https://doi.org/10.1002/2211-5463.13847

2024-06-16

FEBS Open Bio

Abstract:Peptides are increasingly popular as therapeutic agents due to their cost‐effectiveness, low immune response, and high specificity. Many tools study peptides as linear chains, ignoring crucial structural details that affect their properties. Recent advances in peptide structure prediction have improved our understanding. This review highlights the importance of integrating structural information to advance the therapeutic and biotechnological use of peptides. Peptides are attracting a growing interest as therapeutic agents. This trend stems from their cost‐effectiveness and reduced immunogenicity, compared to antibodies or recombinant proteins, but also from their ability to dock and interfere with large protein–protein interaction surfaces, and their higher specificity and better biocompatibility relative to organic molecules. Many tools have been developed to understand, predict, and engineer peptide function. However, most state‐of‐the‐art approaches treat peptides only as linear entities and disregard their structural arrangement. Yet, structural details are critical for peptide properties such as solubility, stability, or binding affinities. Recent advances in peptide structure prediction have successfully addressed the scarcity of confidently determined peptide structures. This review will explore different therapeutic and biotechnological applications of peptides and their assemblies, emphasizing the importance of integrating structural information to advance these endeavors effectively.

biochemistry & molecular biology
A Global Review on Short Peptides: Frontiers and Perspectives

Vasso Apostolopoulos,Joanna Bojarska,Tsun-Thai Chai,Sherif Elnagdy,Krzysztof Kaczmarek,John Matsoukas,Roger New,Keykavous Parang,Octavio Paredes Lopez,Hamideh Parhiz,Conrad O Perera,Monica Pickholz,Milan Remko,Michele Saviano,Mariusz Skwarczynski,Yefeng Tang,Wojciech M Wolf,Taku Yoshiya,Janusz Zabrocki,Piotr Zielenkiewicz,Maha AlKhazindar,Vanessa Barriga,Konstantinos Kelaidonis,Elham Mousavinezhad Sarasia,Istvan Toth

DOI: https://doi.org/10.3390/molecules26020430

IF: 4.6

2021-01-15

Molecules

Abstract:Peptides are fragments of proteins that carry out biological functions. They act as signaling entities via all domains of life and interfere with protein-protein interactions, which are indispensable in bio-processes. Short peptides include fundamental molecular information for a prelude to the symphony of life. They have aroused considerable interest due to their unique features and great promise in innovative bio-therapies. This work focusing on the current state-of-the-art short peptide-based therapeutical developments is the first global review written by researchers from all continents, as a celebration of 100 years of peptide therapeutics since the commencement of insulin therapy in the 1920s. Peptide "drugs" initially played only the role of hormone analogs to balance disorders. Nowadays, they achieve numerous biomedical tasks, can cross membranes, or reach intracellular targets. The role of peptides in bio-processes can hardly be mimicked by other chemical substances. The article is divided into independent sections, which are related to either the progress in short peptide-based theranostics or the problems posing challenge to bio-medicine. In particular, the SWOT analysis of short peptides, their relevance in therapies of diverse diseases, improvements in (bio)synthesis platforms, advanced nano-supramolecular technologies, aptamers, altered peptide ligands and in silico methodologies to overcome peptide limitations, modern smart bio-functional materials, vaccines, and drug/gene-targeted delivery systems are discussed.
Functional-Structural Studies and Biomedical Applications 2.0

Romualdo Troisi,Filomena Sica

DOI: https://doi.org/10.3390/ijms25084279

IF: 5.6

2024-04-12

International Journal of Molecular Sciences

Abstract:As a follow-up to the previous Special Issue "Aptamers: Functional-Structural Studies and Biomedical Applications" [...]

biochemistry & molecular biology,chemistry, multidisciplinary
Polypeptide-Based Systems: From Synthesis to Application in Drug Delivery

Mariia Stepanova,Alexey Nikiforov,Tatiana Tennikova,Evgenia Korzhikova-Vlakh

DOI: https://doi.org/10.3390/pharmaceutics15112641

IF: 6.525

2023-11-21

Pharmaceutics

Abstract:Synthetic polypeptides are biocompatible and biodegradable macromolecules whose composition and architecture can vary over a wide range. Their unique ability to form secondary structures, as well as different pathways of modification and biofunctionalization due to the diversity of amino acids, provide variation in the physicochemical and biological properties of polypeptide-containing materials. In this review article, we summarize the advances in the synthesis of polypeptides and their copolymers and the application of these systems for drug delivery in the form of (nano)particles or hydrogels. The issues, such as the diversity of polypeptide-containing (nano)particle types, the methods for their preparation and drug loading, as well as the influence of physicochemical characteristics on stability, degradability, cellular uptake, cytotoxicity, hemolysis, and immunogenicity of polypeptide-containing nanoparticles and their drug formulations, are comprehensively discussed. Finally, recent advances in the development of certain drug nanoformulations for peptides, proteins, gene delivery, cancer therapy, and antimicrobial and anti-inflammatory systems are summarized.

pharmacology & pharmacy

From Basic Science to Biomedical Applications—Second Edition

Recent Applications of Retro-Inverso Peptides

From Natural Sources to Therapeutics

Peptide Drugs: Current Status and it's Applications in the Treatment of Various Diseases

The Search for Peptide-Based Therapeutics Using Computational Tools

Peptides for therapeutic applications – challenges and chances

Peptides as drugs: from screening to application

Advancements in peptide-based therapeutics: Design, synthesis and clinical applications

Therapeutic Peptides and Proteins: Stabilization Challenges and Biomedical Applications by Means of Nanodelivery Systems

The Medicinal Chemistry of Therapeutic Peptides: Recent Developments in Synthesis and Design Optimizations

The Century-Long Journey of Peptide-Based Drugs

Overcoming the shortcomings of peptide-based therapeutics

Peptide-Based Biomaterials for Combatting Infections and Improving Drug Delivery

Recent CPP-based applications in medicine

Recent Advances and Computational Approaches in Peptide Drug Discovery

Peptides as Targeting Agents and Therapeutics: A Brief Overview

Therapeutic peptides: current applications and future directions

Structural information in therapeutic peptides: Emerging applications in biomedicine

A Global Review on Short Peptides: Frontiers and Perspectives

Functional-Structural Studies and Biomedical Applications 2.0

Polypeptide-Based Systems: From Synthesis to Application in Drug Delivery